PT - JOURNAL ARTICLE AU - Smith, Danielle AU - Bastug, Kristen AU - Burgoine, Kathy AU - Broach, James R. AU - Hehnly, Christine AU - Morton, Sarah U. AU - Osman, Marwan AU - Schiff, Steven J. AU - Ericson, Jessica E. TI - Human <em>Paenibacillus</em> Infections: A Systematic Review with Comparison of Adult and Infant Cases AID - 10.1101/2023.09.19.23295794 DP - 2023 Jan 01 TA - medRxiv PG - 2023.09.19.23295794 4099 - http://medrxiv.org/content/early/2023/09/20/2023.09.19.23295794.short 4100 - http://medrxiv.org/content/early/2023/09/20/2023.09.19.23295794.full AB - Neonatal infections due to Paenibacillus species have increasingly been reported over the last few years. We performed a structured literature review of human Paenibacillus infections in infants and adults to compare the epidemiology of infections between these distinct patient populations. Thirty-nine reports describing 176 infections met our inclusion criteria and were included. There were 37 Paenibacillus infections occurring in adults caused by 23 species. The clinical presentations of infections were quite variable. In contrast, infections in infants were caused by only 3 species: P. thiaminolyticus (112/139, 80%), P. alvei (2/139, 1%) and P. dendritiformis (2/139, 1%). All of the infants with Paenibacillus infection presented with a sepsis syndrome or meningitis, often complicated by extensive cerebral destruction and hydrocephalus. Outcomes were commonly poor with 17% (24/139) mortality. Cystic encephalomalacia due to brain destruction was common in both Ugandan and American cases and 92/139 (66%) required surgical management of hydrocephalus following their infection. Paenibacillus infections are likely underappreciated in infants and effective treatments are urgently needed.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded by the National Institutes of Health under NIH Director Pioneer Award 1DP1HD086071 and NIH Director Transformative Award 1R01AI145057 to S.J.S. J.E.E. was supported by the National Center for Advancing Translational Sciences, National Institutes of Health, through Grant UL1TR002014. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present work are contained in the manuscript.